The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000864325
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
18/05/2026
Date registered
Help: Date registered
15/07/2026
Date last updated
Help: Date last updated
15/07/2026
Date data sharing statement initially provided
Help: Data sharing statement date
15/07/2026
Type of registration
Help: Type of registration
Retrospectively registered

Titles & IDs
Public title
Transforming access, relational care, and primary health care in an urban Aboriginal and Torres Strait Islander population through patient-centred medical homes: a prospective cohort study using mixed methods
Scientific title
A prospective mixed methods cohort implementation and evaluation of the Institute for Urban Indigenous Health (IUIH) System of Care, Version 2 (ISoC2), a patient centred medical home model in Aboriginal Community Controlled Health Organisation primary health care for urban Aboriginal and Torres Strait Islander populations
Additional trial identifiers [1] 317323 0
Nil
Universal Trial Number (UTN)
Trial acronym
ISoC2
Related trial records

Health condition
Health condition(s) studied:
Diabetes 341968 0
Cardiovascular disease 342349 0
Emotional wellbeing 342350 0
Condition category
Condition code
Public Health 338043 338043 0 0
Health service research
Metabolic and Endocrine 338444 338444 0 0
Diabetes
Cardiovascular 338445 338445 0 0
Other cardiovascular diseases

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
The intervention is the Institute for Urban Indigenous Health System of Care version 2 (ISoC2), a reformed model of primary health care implemented within Aboriginal and Torres Strait Islander community-controlled health services. ISoC2 represents a system-level redesign of care delivery grounded in Aboriginal ways of Respect (for clients’ stories), Connection (with clients and their families), and Kinship (ways of working together). It shifts care from episodic, provider-driven interactions to continuous, relationship-based, team-delivered care that is proactive, coordinated, and responsive to client and community needs. The intervention has been implemented at two community-controlled primary health care clinics in Southeast Queensland, Moreton Aboriginal and Torres Strait Islander Community Health Service (MATSICHS) and Kalwun Coomera Integrated Health and Wellbeing Hub. Care is delivered in clinic settings and, where appropriate, in community and home-based contexts by multidisciplinary primary health care teams as part of routine service delivery. Participants are not randomised; allocation is based on clinic of attendance, with matched comparison groups from non-intervention clinics.

A core feature of ISoC2 is client enrolment (empanelment) into a multidisciplinary care team (“Pod”), a structural change designed to enhance continuity, accountability, and coordination of care. Enrolment is voluntary and occurs when clients engage with the service (e.g. self-presentation, referral, or existing clients). Each Pod includes a Reception/Admin staff member, an Aboriginal Health Worker (AHW), nurse, and general practitioner. Clients are empanelled within a Pod for the duration of their engagement with the service, with flexibility to move between Pods if requested. Initial and ongoing care includes the standard wholistic assessment of physical health, wellbeing (including social, emotional, cultural, and practical dimensions) and identification of client priorities, including acute and chronic care needs, preventive health, and client identified goals. Care pathways are dynamic and individualised, responding to each client’s clinical needs, goals, priorities and context rather than fixed or provider driven protocols.

Care is delivered through team-based, multidisciplinary practice. ISoC2 transforms care delivery through shared responsibility across Pod members, supported by daily team “huddles,” shared electronic health records including care plans where appropriate, and data-driven quality improvement processes to support proactive care management of empanelled clients. Strengthened relational care is embedded within the Pod model and involves sustained, culturally safe relationships between clients and their care team, with all team members sharing responsibility for connection, trust, and continuity of care, supported by consistent engagement, proactive follow-up, and flexible communication.

Pod members routinely support goal setting and client-led decision-making using tools such as the Australian Therapy Outcome Measure for Indigenous Clients (ATOMIC). ISoC2 offers clients flexible and responsive access to services, enabling care delivery via face-to-face consultations, telephone contact, and home or community visits, including extended hours where required. This supports improved accessibility, responsiveness, and continuity of care. Workforce transformation is supported through expanded and intersecting scopes of practice across Pod members, particularly non-GP providers. This is complemented by training and ongoing professional development delivered in-house or externally, both prior to and during implementation. Staff undergo a series of training modules, including a one-day workshop in the preceding 1-2 months prior to implementation, provided by trained facilitators from the service development team. Ongoing training and support provided by the service development team on a weekly and ad hoc basis. Quarterly workshop will be convened throughout to the intervention period for participating sites and staff to share learnings and reinforce concepts of the model. Healthcare resources are allocated using a data-driven, wholistic assessment of client needs. Intervention fidelity is monitored through routinely collected clinical and administrative data (e.g. electronic medical records, care plans, follow-up activities), alongside service-level quality improvement processes and audits of Pod functioning, including data dashboards providing information of empanelment, continuity of Pod team and distribution of care between Pod team members.

The intervention is delivered continuously as part of routine care, with participants exposed to the model for the duration of their engagement with the service during the study period, rather than for a fixed number of sessions or time-limited program.
Intervention code [1] 334356 0
Treatment: Other
Description of the comparator or control
The comparator is standard primary health care delivered at non-intervention Aboriginal and Torres Strait Islander community-controlled health service clinics that have not implemented the ISoC2 model of care. These services provide usual care under existing models prior to system redesign.

In usual care, clients are not routinely allocated to a particular provider, although typically clients will see a specific general practitioner based on their preference or provider availability. Care is delivered by multidisciplinary staff; however, providers often work predominantly independently in parallel rather than collaboratively, with team-based care planning occurring on an intermittent basis.

Care pathways generally follow a structured sequence, with administrative staff as the initial point of contact, followed by nurses and/or Aboriginal Health Workers, and then general practitioners, who coordinate referrals to allied health or specialist services as required. Scope of practice is aligned with traditional discipline-specific roles.

Relationship-based care is primarily centred on the interaction between the client and general practitioner, with shared decision-making occurring within clinical consultations. Services are delivered using multiple modalities, although care is predominantly provided through face-to-face consultations.

For quantitative analyses, comparison groups are derived from routinely collected electronic health record data from matched non-intervention clinics, as well as matched control participants from the Mayi Kuwayu Study cohort, based on demographic and health characteristics. The Mayi Kuwayu Study cohort comprises Aboriginal and Torres Strait Islander people aged 16 years and over from across Australia who complete a national survey every three years to collect longitudinal data on culture, health and wellbeing.

Control group
Active

Outcomes
Primary outcome [1] 345458 0
Catchment coverage, defined as the proportion of regular clients within the estimated catchment population attending each clinic
Timepoint [1] 345458 0
Annual measurements across the study period (2016–2024)
Primary outcome [2] 345459 0
Continuity of Care: Longitudinal provider-patient continuity of care measured by the Usual Provider of Care (UPC) index
Timepoint [2] 345459 0
Calculated over a 2-year rolling period across the study period (2016-2024)
Primary outcome [3] 345460 0
Glycaemic control: proportion of clients with type 2 diabetes achieving HbA1c 2% reduction from baseline
Timepoint [3] 345460 0
Annual measurements across the study period (2016-2024)
Secondary outcome [1] 461728 0
Cardiovascular Risk: Proportion of clients at high absolute risk of cardiovascular disease
Timepoint [1] 461728 0
Annual measurements across the study period (2016-2024)
Secondary outcome [2] 461729 0
Potentially preventable hospitalisations: Rates of potentially preventable hospitalisations and emergency department presentations. This will be assessed as a composite outcome.
Timepoint [2] 461729 0
Annual measurements across the study period (2016-2024)
Secondary outcome [3] 461730 0
Access: Realised access, defined as the proportion of regular clients in the preceding 12 months, who used a GP/RN/AHW service in each month, and ii) the ratio of regular clients who used a service each month to the average Full-Time Equivalent (FTE) GPs each calendar year. This will be assessed as a composite measure.
Timepoint [3] 461730 0
Monthly measurements from baseline to end of study period (2014-2024)
Secondary outcome [4] 461731 0
Relational Care: Client-reported relational care
Timepoint [4] 461731 0
Measured at the time of survey completion during the study period (2020-2023)
Secondary outcome [5] 461732 0
Client enablement: Client-reported client enablement
Timepoint [5] 461732 0
Measured at the time of survey completion during the study period (2020-2023)
Secondary outcome [6] 461733 0
Client-reported wellbeing (general health)
Timepoint [6] 461733 0
Measured at the time of survey completion during the study period (2020–2023)
Secondary outcome [7] 461734 0
Wellbeing – Life satisfaction: Client-reported wellbeing (life satisfaction)
Timepoint [7] 461734 0
Measured at the time of survey completion during the study period (2020–2023)
Secondary outcome [8] 461735 0
Wellbeing – Life control: Client-reported wellbeing outcome (life control)
Timepoint [8] 461735 0
Measured at the time of survey completion during the study period (2020–2023)
Secondary outcome [9] 461736 0
Psychological distress: Client reported wellbeing outcome (psychological distress)
Timepoint [9] 461736 0
Measured at the time of survey completion during the study period (2020–2023)
Secondary outcome [10] 463112 0
Wellbeing – Cultural wellbeing: Client-reported wellbeing outcome (cultural wellbeing)
Timepoint [10] 463112 0
Measured at the time of survey completion during the study period (2020–2023)
Secondary outcome [11] 463113 0
Emergency Department presentations: Rates of emergency department presentations. This will be assessed as a composite outcome
Timepoint [11] 463113 0
Annual rates across the study period (2016-2024)
Secondary outcome [12] 463114 0
Cost effectiveness - Health service costs: Differences in total health service costs associated with the ISoC2 model of care compared with standard care.
Timepoint [12] 463114 0
Measured over the study period (2016–2024), including pre-implementation and post-implementation periods, with sensitivity analyses across defined time periods.
Secondary outcome [13] 463115 0
Cost effectiveness - MBS billing utilisation: differences in Medicare Benefits Schedule (MBS) billing utilisation associated with the ISoC2 model of care compared with standard care.
Timepoint [13] 463115 0
Measured over the study period (2016–2024), including pre implementation and post implementation periods
Secondary outcome [14] 463116 0
Cost effectiveness - Hospital utilisation: Differences in hospital utilisation associated with the ISoC2 model of care compared with standard care
Timepoint [14] 463116 0
Measured over the study period (2016–2024), including pre-implementation and post-implementation periods
Secondary outcome [15] 463117 0
Model delivery and service processes – Client enrolment fidelity: Proportion of total visits conducted with the assigned pod team (client enrolment fidelity).
Timepoint [15] 463117 0
Measured at regular intervals (e.g., monthly or annual summaries) across the study period (2016–2024)
Secondary outcome [16] 463118 0
Model delivery and service processes – Provider type distribution: Distribution of consultations by provider type (GP, RN, AHW/HWW)
Timepoint [16] 463118 0
Measured at regular intervals (e.g., monthly or annual summaries) across the study period (2016–2024)
Secondary outcome [17] 463121 0
Model delivery and service processes – Consultation modality: Proportion of consultations delivered by modality (face-to-face, telephone, home visit)
Timepoint [17] 463121 0
Measured at regular intervals (e.g., monthly or annual summaries) across the study period (2016–2024)
Secondary outcome [18] 463124 0
Model delivery and service processes – GP appointment availability: Third next available appointment (days) for general practitioners
Timepoint [18] 463124 0
Measured at regular intervals (e.g., monthly or annual summaries) across the study period (2016–2024)
Secondary outcome [19] 463125 0
Implementation acceptability and feasibility – barriers and enablers: Staff reported barriers and enablers to implementation of the ISoC2 model of care
Timepoint [19] 463125 0
Collected during the study post-implementation phase (2016-2024)
Secondary outcome [20] 463126 0
Implementation acceptability and feasibility –barriers and enablers: Client-reported acceptability of the ISoC2 model of care
Timepoint [20] 463126 0
Collected during the study post-implementation phase (2021-2024)
Secondary outcome [21] 463127 0
Implementation acceptability and feasibility – acceptability of care: Staff-reported acceptability of the ISoC2 model of care
Timepoint [21] 463127 0
Collected during the study post-implementation phase (2021-2024)
Secondary outcome [22] 464398 0
Implementation acceptability and feasibility – acceptability of care: Client-reported acceptability of the ISoC2 model of care
Timepoint [22] 464398 0
Collected post-implementation during the study period (2021-2024)
Secondary outcome [23] 464399 0
Implementation acceptability and feasibility – experience of care delivery: Staff-reported experiences of team-based and relational care delivery
Timepoint [23] 464399 0
Collected post-implementation during the study period (2021-2024)
Secondary outcome [24] 464400 0
Implementation acceptability and feasibility – experience of care delivery: Client-reported experiences of team-based and relational care delivery
Timepoint [24] 464400 0
Yarns were conducted by a Researcher one-on-one with a client using a mix of ‘social yarning’, ‘research topic yarning’ and ‘collaborative yarning’ as described by Bessarab and Ng’andu (2010) with up to 25 clients. 30-60 minutes were allocated per client yarn. Analysis of the yarns employed a cyclical approach to thematic analysis, undergoing independent and peer review for code development, with axial codes reviewed through exposure to sensemaking and consensus-based decision-making.

Eligibility
Key inclusion criteria
- Staff and regular clients of Moreton Aboriginal and Torres Strait Islander Community Health Service (MATSICHS) Caboolture and Kalwun Coomera Integrated Health and Wellbeing Hub.
- Clients (survey and qualitative components): consent based. Regular clients (defined as at least three visits in the preceding 24 months, are eligible to participate if they are registered with MATSICHS Caboolture or Coomera Integrated Health and Wellbeing Hub, (at least 18 years of age), Aboriginal and/or Torres Strait Islander, and provide informed consent.
- Eligible clients can choose to consent to participate in one or more components: complete a survey and/or participate in a qualitative interview.
- Clients (survey comparison group): consent based. Matched control participants drawn from the Mayi Kuwayu Study cohort.
- Clients (EHR quantitative component only): Waiver of consent. For analysis of routinely collected electronic health record (EHR) data, study participants will include regular clients (as defined above) from intervention and non-intervention clinics. This dataset will comprise de-identified data accessed under an ethics-approved waiver of consent. This component may include clients aged less than 12 months of age and over.
- Staff participants (qualitative components): consent based. Staff who are currently employed at MATSICHS Caboolture or Kalwun Coomera Integrated Health and Wellbeing Hub or were employed at either clinic during implementation of ISoC2 and provide informed consent.

Minimum age
No limit
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
Yes
Key exclusion criteria
Non regular clients (defined as < 3 visits in the preceding 24 months)

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Other
Other design features
Non-randomised prospective cohort (hybrid implementation–effectiveness) with pre–post analysis and matched controls; mixed-methods evaluation.
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
This study used a mixed-methods design consistent with Indigenous research approaches, with qualitative and client-reported data informing interpretation of quantitative outcomes.

Qualitative data from yarning with clients and staff were collected following implementation and analysed thematically to assess acceptability of the model of care and identify barriers and enablers to implementation.

Survey data (including relational care, client enablement and wellbeing outcomes) were analysed as cross-sectional data. Outcomes were categorised according to validated measures and analysed using regression models to examine associations, with adjustment for age, gender, education and healthcare access.

Quantitative analyses of routinely collected electronic health records and linked hospital data were used to examine health service and clinical outcomes over the study period (2016–2024). Longitudinal analyses, including interrupted time series and regression models, were used to assess changes associated with implementation of the ISoC2 model, accounting for autocorrelation and seasonality where appropriate. Clinical and hospital outcomes were analysed using generalised linear mixed models with adjustment for age, sex and health characteristics.

Economic analyses examined differences in service utilisation and associated costs between intervention and standard care groups using routinely collected data (including primary care activity, MBS service items and hospital use), with adjustment for population characteristics and sensitivity analyses across time periods.

The study was powered based on the primary outcome of catchment coverage, with all sample size calculations conducted assuming 80% power and a two-sided significance level of 0.05. The protocol specified a required sample size of 1,520 individuals to detect a minimum absolute difference of 5 percentage points (from 38.5% pre-implementation to 43.5% post-implementation) using an independent Chi Square test.

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD

Funding & Sponsors
Funding source category [1] 321889 0
Government body
Name [1] 321889 0
Department of Health, Disability and Ageing Medical Research Future Fund (MRFF)
Country [1] 321889 0
Australia
Primary sponsor type
University
Name
UQ Poche Centre, University of Queensland
Address
Country
Australia
Secondary sponsor category [1] 324752 0
Other Collaborative groups
Name [1] 324752 0
The Institute for Urban Indigenous Health (IUIH)
Address [1] 324752 0
Country [1] 324752 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320429 0
The University of Queensland Human Research Ethics Committee A
Ethics committee address [1] 320429 0
Ethics committee country [1] 320429 0
Australia
Date submitted for ethics approval [1] 320429 0
15/06/2021
Approval date [1] 320429 0
30/07/2021
Ethics approval number [1] 320429 0
2021/HE000529

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 150454 0
Prof James Ward
Address 150454 0
University of Queensland Poche Centre for Indigenous Health, 74 High St, Toowong QLD 4066
Country 150454 0
Australia
Phone 150454 0
+61 0439 605227
Fax 150454 0
Email 150454 0
Contact person for public queries
Name 150455 0
Prof James Ward
Address 150455 0
University of Queensland Poche Centre for Indigenous Health, 74 High St, Toowong QLD 4066
Country 150455 0
Australia
Phone 150455 0
+61 7 344 38276
Fax 150455 0
Email 150455 0
Contact person for scientific queries
Name 150456 0
Prof James Ward
Address 150456 0
University of Queensland Poche Centre for Indigenous Health, 74 High St, Toowong QLD 4066
Country 150456 0
Australia
Phone 150456 0
+61 7 344 38276
Fax 150456 0
Email 150456 0

Data sharing statement
Will the study consider sharing individual participant data?
No
No IPD sharing reason/comment: Potentially sensitive data of Aboriginal and Torres Strait Islander Peoples



What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.